Zavzpret Nasal Spray Approved to Treat Migraines

MONDAY, March 13, 2023 -- The U.S. Food and Drug Administration has approved Pfizer's zavegepant (Zavzpret), a calcitonin gene-related peptide receptor antagonist nasal spray meant to treat severe headache pain, the company announced Friday.

"The...